Related Experiment Video

Updated: Aug 13, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

818

EZH2: An Accomplice of Gastric Cancer

Wuhan Yu1,2, Ning Liu1,3, Xiaogang Song1,4

  • 1The Second Hospital of Lanzhou University, Lanzhou 730030, China.

Cancers
|January 21, 2023
PubMed

Insights

Enhancer of zeste homolog 2 (EZH2) promotes gastric cancer progression and chemoresistance. Targeting EZH2 offers a promising therapeutic strategy for improving patient outcomes in gastric cancer treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Gastric cancer is a leading cause of cancer deaths globally.
  • Epigenetic mechanisms, including Enhancer of zeste homolog 2 (EZH2) activity, play a crucial role in gastric cancer development.
  • Understanding EZH2's role is vital for effective gastric cancer therapy.

Purpose of the Study:

  • To comprehensively review the multifaceted roles of EZH2 in gastric cancer.
  • To elucidate the mechanisms of EZH2 overexpression in cancer.
  • To summarize EZH2's impact on gastric cancer susceptibility, carcinogenesis, metastasis, drug resistance, and prognosis.

Main Methods:

  • Literature review of studies on EZH2 and gastric cancer.
  • Analysis of EZH2's epigenetic regulatory mechanisms.
  • Synthesis of evidence linking EZH2 to gastric cancer progression and therapeutic resistance.

Main Results:

  • EZH2 is overexpressed in gastric cancer, promoting tumor progression via multiple pathways.
  • EZH2 is associated with genetic susceptibility, carcinogenesis, and invasive metastasis.
  • EZH2-mediated chemoresistance and its link to poor prognosis are significant findings.

Conclusions:

  • EZH2 is a key epigenetic regulator implicated in gastric cancer pathogenesis.
  • Targeting EZH2 presents a viable strategy to overcome chemoresistance and improve patient prognosis.
  • Further research into EZH2/PRC2 inhibition is crucial for developing novel gastric cancer therapies.
Keywords:
H3K27enhancer of zeste homolog 2epigeneticsgastric cancer

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K